Takahiro Shoji

Lower risk for cardiovascular mortality in oral 1 -hydroxy vitamin D3 users in a haemodialysis population

Takahiro Shoji, K. Shinohara, Emi Kimoto et al. · Nephrology Dialysis Transplantation · 2003 · 352 citations · Full text

Medicine, Nephrology, Dialysis +16

Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients.

Takahiro Shoji, Y Nishizawa, Takahiko Kawagishi et al. · Journal of the American Society of Nephrology · 1998 · 184 citations · Full text

Medicine, Nephrology, Dialysis +16

Effect of cisplatin on the activities of enzymes which protect against lipid peroxidation

Yasuyuki Sadzuka, Takahiro Shoji, Yoshio Takino · Biochemical Pharmacology · 1992 · 139 citations

Life Sciences, Biochemistry, Pharmacology +12

Inhibition of VEGF (Vascular Endothelial Growth Factor)-A or its Receptor Activity Suppresses Experimental Aneurysm Progression in the Aortic Elastase Infusion Model

Baohui Xu, Yasunori Iida, Keith Glover et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2019 · 75 citations · Full text

Medicine, Molecular Medicine, Pharmacology +17

Mechanism of the increase in lipid peroxide induced by cisplatin in the kidneys of rats

Yasuyuki Sadzuka, Takahiro Shoji, Yoshio Takino · Toxicology Letters · 1992 · 69 citations

Medicine, Pharmacology, Toxicology +12